William Patalon III
Over the last five years, we’ve been detailing the big new threat posed by the nuclear buildups in China and Russia, and by a nuclearizing North Korea.
We’ve also chronicled the major threat posed by the “New Arms Race” ignited by hypersonic weapons – both conventional and nuclear-tipped. (In fact, we even told you about the new hypersonic spyplane the military plans to build.)
Our goal of course, was to spotlight the need for new types of missile-defense systems – while zeroing in on the stocks most likely to benefit from the development of these newest technologies.
And to keep you ahead of the crowd.
It appears we’ve done just that: A brand-new (and high-level) study from a Washington think tank is raising worries about the very same threats we’ve been telling you about for years.
alternative investments: CNO Financial Group, Inc.(CNO)
- [By Paul Ausick]
CNO Financial Group Inc. (NYSE: CNO) dropped about 8.1% on Friday to post a new 52-week low of $14.29 against a 52-week high of $20.88. Volume of more than 6 million was more than 3 times the daily average of around 1.8 million. The stock closed at $15.55 on Thursday night. The company on Thursday cut its re-insurance agreements with Beechwood Re following disclosure that regulators that many of Beechwood’s assets did not comply with insurance company guidelines.
alternative investments: Gilead Sciences, Inc.(GILD)
- [By Ben Levisohn]
JPMorgan is hosting its health care conference this week, which has provided opportunities for companies to provide updates on their pipelines, profits and even M&A plans before a captive audience. And of course, Gilead Sciences (GILD) was there, and its management spoke to analysts about its business, including the possibility for…M&A, which we don’t need to remind you is much on investors’ minds. Mizuho’s Salim Syed offered his takeaway on the subject:
- [By Laurie Kulikowski]
The company’s current return on equity greatly increased when compared to its ROE from the same quarter one year prior. This is a signal of significant strength within the corporation. Compared to other companies in the Biotechnology industry and the overall market, GILEAD SCIENCES INC’s return on equity significantly exceeds that of both the industry average and the S&P 500.
- [By Arie Goren]
Also Read :Gilead Sciences, Inc: Gilead (GILD) Stock Looks Set For A Bounce
Latest Quarter Results
On November 01, Gilead Sciences reported its third quarter 2016 financial results, which missed earnings per share expectations by $0.11 (3.8%). GILD’s revenues of $7.50 billion for the quarter were better than the consensus estimate of $7.46 billion. The company showed earnings per share surprise in nine of its last twelve five quarters, as shown in the table below.
alternative investments: The Joint Corp.(JYNT)
- [By Monica Gerson]
Joint Corp (NASDAQ: JYNT) is estimated to post a quarterly loss at $0.28 per share on revenue of $4.13 million.
Synacor Inc (NASDAQ: SYNC) is projected to post a quarterly loss at $0.03 per share on revenue of $30.00 million.
alternative investments: Berkshire Hathaway Inc. (BRK-A)
- [By Andrew Tonner]
In fact, some of businesses’ biggest names trade at significant discounts to the market, including companies like Warren Buffett’s Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK.B), Cisco Systems (NASDAQ:CSCO), and International Business Machines (NYSE:IBM). As such, let’s dive into what specifically makes these value stocks particularly intriguing investing opportunities today.
- [By Matthew Frankel]
I won’t keep you in suspense — Warren Buffett-led Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) owns 400,000,000 shares of Coca-Cola (NYSE:KO), worth a total of $16.7 billion as of this writing. This translates to a 9.4% stake in the beverage giant, and makes Coca-Cola Buffett’s third-largest stock investment.
- [By Demitrios Kalogeropoulos]
The next few trading days include highly anticipated earnings reports from some of the biggest names in their respective industries, including Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B), Costco (NASDAQ:COST), and Priceline (NASDAQ:PCLN).
- [By Paul Ausick]
Among other stories related to the company last week, Warren Buffett’s Berkshire Hathaway Inc. (NYSE: BRK-A) reported that it now owns about 57.4 million shares of Apple stock, up from 15.23 million at the end of the third quarter of 2016.